evobrutinib,SAR443820
merck,sanofi
['multiple sclerosis', 'evobrutinib', 'pola', 'rova,(-approval),(-microvascular)', 'merck']
excited to talk at #aan23 on 2 new mols for #multiplesclerosis .#evobrutinib (a btk inhibitor) showing a favorable efficacy and safety profile after 4.5 y and the design of a phase 2 trial with #ripk1. trying to deal with progressive disease! 
Professor of Neurology, Chair Department of Neurology, Campus Hospitalari Vall d'Hebron @vallhebron (Barcelona), Director @Cemcat_em . Opinions are my own